Exos Asset Management LLC - BIOTECH ACQUISITION COMPANY ownership

BIOTECH ACQUISITION COMPANY's ticker is BIOTW and the CUSIP is G1125A116. A total of 22 filers reported holding BIOTECH ACQUISITION COMPANY in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Exos Asset Management LLC ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q3 2021$8,000
-27.3%
12,407
-0.7%
0.00%
-33.3%
Q2 2021$11,000
+37.5%
12,5000.0%0.01%0.0%
Q1 2021$8,00012,5000.01%
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q1 2021
NameSharesValueWeighting ↓
Kingstown Capital 300,000$18,0000.06%
Radcliffe Capital Management, L.P. 202,950$2,014,0000.05%
RAMIUS ADVISORS LLC 567,986$34,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 63,832$633,0000.02%
MARSHALL WACE, LLP 575,000$5,709,0000.01%
Telemetry Investments, L.L.C. 153,694$9,0000.01%
Q Global Advisors, LLC 300,000$15,0000.01%
LMR Partners LLP 50,000$496,0000.01%
Segantii Capital Management Ltd 25,000$248,0000.01%
Corbin Capital Partners, L.P. 464,062$28,0000.01%
View complete list of BIOTECH ACQUISITION COMPANY shareholders